Ritlecitinib Shows Long-Term Benefits in Alopecia Areata

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% scalp hair loss.
Medscape Medical News

source https://www.medscape.com/viewarticle/ritlecitinib-shows-long-term-benefits-alopecia-areata-2025a10002wo?src=rss